☰

Lili Yang - Publications

Affiliations: 
2004 California Institute of Technology, Pasadena, CA 
Tree Info Similar researchers PubMed Report error

38 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Li YR, Wilson M, Yang L. Target tumor microenvironment by innate T cells. Frontiers in Immunology. 13: 999549. PMID 36275727 DOI: 10.3389/fimmu.2022.999549  0.315
2022 Li YR, Zeng S, Dunn ZS, Zhou Y, Li Z, Yu J, Wang YC, Ku J, Cook N, Kramer A, Yang L. Off-the-shelf third-party HSC-engineered iNKT cells for ameliorating GvHD while preserving GvL effect in the treatment of blood cancers. Iscience. 25: 104859. PMID 36034226 DOI: 10.1016/j.isci.2022.104859  0.304
2021 Nesterenko PA, McLaughlin J, Tsai BL, Burton Sojo G, Cheng D, Zhao D, Mao Z, Bangayan NJ, Obusan MB, Su Y, Ng RH, Chour W, Xie J, Li YR, Lee D, ... ... Yang L, et al. HLA-A02:01 restricted T cell receptors against the highly conserved SARS-CoV-2 polymerase cross-react with human coronaviruses. Cell Reports. 110167. PMID 34919800 DOI: 10.1016/j.celrep.2021.110167  0.72
2021 Li YR, Zhou Y, Kim YJ, Zhu Y, Ma F, Yu J, Wang YC, Chen X, Li Z, Zeng S, Wang X, Lee D, Ku J, Tsao T, Hardoy C, ... ... Yang L, et al. Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy. Cell Reports. Medicine. 2: 100449. PMID 34841295 DOI: 10.1016/j.xcrm.2021.100449  0.514
2021 Zhou Y, Li YR, Zeng S, Yang L. Methods for Studying Mouse and Human Invariant Natural Killer T Cells. Methods in Molecular Biology (Clifton, N.J.). 2388: 35-57. PMID 34524660 DOI: 10.1007/978-1-0716-1775-5_4  0.319
2019 Di Biase S, Ma X, Wang X, Yu J, Wang YC, Smith DJ, Zhou Y, Li Z, Kim YJ, Clarke N, To A, Yang L. Creatine uptake regulates CD8 T cell antitumor immunity. The Journal of Experimental Medicine. PMID 31628186 DOI: 10.1084/Jem.20182044  0.404
2019 Zhu Y, Smith DJ, Zhou Y, Li YR, Yu J, Lee D, Wang YC, Di Biase S, Wang X, Hardoy C, Ku J, Tsao T, Lin LJ, Pham AT, Moon H, ... ... Yang L, et al. Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer. Cell Stem Cell. PMID 31495780 DOI: 10.1016/J.Stem.2019.08.004  0.557
2019 Sun Q, Zhang X, Wang L, Gao X, Xiong Y, Liu L, Wei F, Yang L, Ren X. T-cell receptor gene therapy targeting melanoma-associated antigen-A4 by silencing of endogenous TCR inhibits tumor growth in mice and human. Cell Death & Disease. 10: 475. PMID 31209257 DOI: 10.1038/s41419-019-1717-8  0.308
2018 Puig-Saus C, Parisi G, Garcia-Diaz A, Krystofinski PE, Sandoval S, Zhang R, Champhekar AS, McCabe J, Cheung-Lau GC, Truong NA, Vega-Crespo A, Komenan MDS, Pang J, Macabali MH, Saco JD, ... ... Yang L, et al. IND-enabling studies for a clinical trial to genetically program a persistent cancer-targeted immune system. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30409823 DOI: 10.1158/1078-0432.Ccr-18-0963  0.619
2018 Bethune MT, Li XH, Yu J, McLaughlin J, Cheng D, Mathis C, Moreno BH, Woods K, Knights AJ, Garcia-Diaz A, Wong S, Hu-Lieskovan S, Puig-Saus C, Cebon J, Ribas A, ... Yang L, et al. Isolation and characterization of NY-ESO-1-specific T cell receptors restricted on various MHC molecules. Proceedings of the National Academy of Sciences of the United States of America. PMID 30348802 DOI: 10.1073/Pnas.1810653115  0.606
2018 Nowicki TS, Escuin-Ordinas H, Avramis E, Chmielowski B, Chodon T, Berent-Maoz B, Wang X, Kaplan-Lefko P, Yang L, Baltimore D, Economou JS, Ribas A, Comin-Anduix B. Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy Products. Journal of Immunotherapy (Hagerstown, Md. : 1997). PMID 29470191 DOI: 10.1097/Cji.0000000000000216  0.542
2017 Li B, Wang X, Choi IY, Wang YC, Liu S, Pham AT, Moon H, Smith DJ, Rao DS, Boldin MP, Yang L. miR-146a modulates autoreactive Th17 cell differentiation and regulates organ-specific autoimmunity. The Journal of Clinical Investigation. PMID 28872459 DOI: 10.1172/Jci94012  0.537
2017 Kim JT, Liu Y, Kulkarni RP, Lee KK, Dai B, Lovely G, Ouyang Y, Wang P, Yang L, Baltimore D. Dendritic cell-targeted lentiviral vector immunization uses pseudotransduction and DNA-mediated STING and cGAS activation. Science Immunology. 2. PMID 28733470 DOI: 10.1126/Sciimmunol.Aal1329  0.511
2017 Yang L, Smith D, Liu S, Ji S, Liu B. Abstract 3769: Stem cell-engineered invariant natural killer T cells for cancer therapy Immunology. 77: 3769-3769. DOI: 10.1158/1538-7445.Am2017-3769  0.349
2015 Smith DJ, Liu S, Ji S, Li B, McLaughlin J, Cheng D, Witte ON, Yang L. Genetic engineering of hematopoietic stem cells to generate invariant natural killer T cells. Proceedings of the National Academy of Sciences of the United States of America. 112: 1523-8. PMID 25605948 DOI: 10.1073/Pnas.1424877112  0.571
2014 Chodon T, Comin-Anduix B, Chmielowski B, Koya RC, Wu Z, Auerbach M, Ng C, Avramis E, Seja E, Villanueva A, McCannel TA, Ishiyama A, Czernin J, Radu CG, Wang X, ... ... Yang L, et al. Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 2457-65. PMID 24634374 DOI: 10.1158/1078-0432.Ccr-13-3017  0.625
2014 Yang L, Wang P. Passive immunization against HIV/AIDS by antibody gene transfer. Viruses. 6: 428-47. PMID 24473340 DOI: 10.3390/V6020428  0.354
2012 Yu KK, Aguilar K, Tsai J, Galimidi R, Gnanapragasam P, Yang L, Baltimore D. Use of mutated self-cleaving 2A peptides as a molecular rheostat to direct simultaneous formation of membrane and secreted anti-HIV immunoglobulins. Plos One. 7: e50438. PMID 23209743 DOI: 10.1371/Journal.Pone.0050438  0.62
2012 Hur EM, Patel SN, Shimizu S, Rao DS, Gnanapragasam PN, An DS, Yang L, Baltimore D. Inhibitory effect of HIV-specific neutralizing IgA on mucosal transmission of HIV in humanized mice. Blood. 120: 4571-82. PMID 23065154 DOI: 10.1182/Blood-2012-04-422303  0.619
2012 Yang L, Boldin MP, Yu Y, Liu CS, Ea CK, Ramakrishnan P, Taganov KD, Zhao JL, Baltimore D. miR-146a controls the resolution of T cell responses in mice. The Journal of Experimental Medicine. 209: 1655-70. PMID 22891274 DOI: 10.1084/Jem.20112218  0.498
2012 Xiao L, Kim J, Lim M, Dai B, Yang L, Reed SG, Baltimore D, Wang P. A TLR4 agonist synergizes with dendritic cell-directed lentiviral vectors for inducing antigen-specific immune responses. Vaccine. 30: 2570-81. PMID 22314134 DOI: 10.1016/J.Vaccine.2012.01.074  0.513
2012 Balazs AB, Chen J, Hong CM, Rao DS, Yang L, Baltimore D. Antibody-based protection against HIV infection by vectored immunoprophylaxis. Nature. 481: 81-4. PMID 22139420 DOI: 10.1038/Nature10660  0.707
2011 Yang L, Yu Y, Kalwani M, Tseng TW, Baltimore D. Homeostatic cytokines orchestrate the segregation of CD4 and CD8 memory T-cell reservoirs in mice. Blood. 118: 3039-50. PMID 21791416 DOI: 10.1182/Blood-2011-04-349746  0.466
2011 Boldin MP, Taganov KD, Rao DS, Yang L, Zhao JL, Kalwani M, Garcia-Flores Y, Luong M, Devrekanli A, Xu J, Sun G, Tay J, Linsley PS, Baltimore D. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. The Journal of Experimental Medicine. 208: 1189-201. PMID 21555486 DOI: 10.1084/Jem.20101823  0.601
2010 Luo XM, Lei MY, Feidi RA, West AP, Balazs AB, Bjorkman PJ, Yang L, Baltimore D. Dimeric 2G12 as a potent protection against HIV-1. Plos Pathogens. 6: e1001225. PMID 21187894 DOI: 10.1371/Journal.Ppat.1001225  0.653
2010 O'Connell RM, Balazs AB, Rao DS, Kivork C, Yang L, Baltimore D. Lentiviral vector delivery of human interleukin-7 (hIL-7) to human immune system (HIS) mice expands T lymphocyte populations. Plos One. 5: e12009. PMID 20700454 DOI: 10.1371/Journal.Pone.0012009  0.719
2010 Baltimore D, Witte ON, Yang L, Economou J, Ribas A. Overcoming barriers to programming a therapeutic cellular immune response to fight melanoma. Pigment Cell & Melanoma Research. 23: 288-9. PMID 20067554 DOI: 10.1111/J.1755-148X.2010.00666.X  0.557
2009 Dai B, Yang L, Yang H, Hu B, Baltimore D, Wang P. HIV-1 Gag-specific immunity induced by a lentivector-based vaccine directed to dendritic cells. Proceedings of the National Academy of Sciences of the United States of America. 106: 20382-7. PMID 19918062 DOI: 10.1073/Pnas.0911742106  0.538
2009 Luo XM, Maarschalk E, O'Connell RM, Wang P, Yang L, Baltimore D. Engineering human hematopoietic stem/progenitor cells to produce a broadly neutralizing anti-HIV antibody after in vitro maturation to human B lymphocytes. Blood. 113: 1422-31. PMID 19059876 DOI: 10.1182/Blood-2008-09-177139  0.527
2008 Chhabra A, Yang L, Wang P, Comin-Anduix B, Das R, Chakraborty NG, Ray S, Mehrotra S, Yang H, Hardee CL, Hollis R, Dorsky DI, Koya R, Kohn DB, Ribas A, et al. CD4+CD25- T cells transduced to express MHC class I-restricted epitope-specific TCR synthesize Th1 cytokines and exhibit MHC class I-restricted cytolytic effector function in a human melanoma model. Journal of Immunology (Baltimore, Md. : 1950). 181: 1063-70. PMID 18606658 DOI: 10.4049/Jimmunol.181.2.1063  0.513
2008 Ziegler L, Yang L, Joo Ki, Yang H, Baltimore D, Wang P. Targeting lentiviral vectors to antigen-specific immunoglobulins. Human Gene Therapy. 19: 861-72. PMID 18590376 DOI: 10.1089/Hum.2007.149  0.536
2008 Yang L, Yang H, Rideout K, Cho T, Joo KI, Ziegler L, Elliot A, Walls A, Yu D, Baltimore D, Wang P. Engineered lentivector targeting of dendritic cells for in vivo immunization. Nature Biotechnology. 26: 326-34. PMID 18297056 DOI: 10.1038/Nbt1390  0.546
2007 Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, Zhang M, McManus MT, Gertler FB, Scott ML, Van Parijs L. Erratum: Corrigendum: A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference Nature Genetics. 39: 803-803. DOI: 10.1038/Ng0607-803  0.37
2006 Yang L, Bailey L, Baltimore D, Wang P. Targeting lentiviral vectors to specific cell types in vivo. Proceedings of the National Academy of Sciences of the United States of America. 103: 11479-84. PMID 16864770 DOI: 10.1073/Pnas.0604993103  0.505
2005 Yang L, Baltimore D. Long-term in vivo provision of antigen-specific T cell immunity by programming hematopoietic stem cells. Proceedings of the National Academy of Sciences of the United States of America. 102: 4518-23. PMID 15758071 DOI: 10.1073/Pnas.0500600102  0.553
2003 Antov A, Yang L, Vig M, Baltimore D, Van Parijs L. Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance. Journal of Immunology (Baltimore, Md. : 1950). 171: 3435-41. PMID 14500638 DOI: 10.4049/Jimmunol.171.7.3435  0.478
2003 Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, Rooney DL, Zhang M, Ihrig MM, McManus MT, Gertler FB, Scott ML, Van Parijs L. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nature Genetics. 33: 401-6. PMID 12590264 DOI: 10.1038/Ng1117  0.344
2002 Yang L, Qin XF, Baltimore D, Van Parijs L. Generation of functional antigen-specific T cells in defined genetic backgrounds by retrovirus-mediated expression of TCR cDNAs in hematopoietic precursor cells. Proceedings of the National Academy of Sciences of the United States of America. 99: 6204-9. PMID 11983911 DOI: 10.1073/Pnas.092154599  0.556
Show low-probability matches.